The university sees R&D as a means of diversifying funding and taking advantage of its 600 researchers. Commercialisation of research is a crucial activity. Results are substantial but limited: in 2008 the Technion Research and Development Foundation was directly involved in initiating six new companies in areas such as medical equipment, environment embryonic stem cells, alternative energy and imaging system. In addition, licensing agreements were signed by the faculty.